Type 2 immunity drives progression of NAFLD

被引：0
|
作者：
Katrina Ray
机构：
来源：
Nature Reviews Gastroenterology & Hepatology | 2017年 / 14卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：505 / 505
相关论文
共 50 条
  • [1] NAFLD Type 2 immunity drives progression of NAFLD
    Ray, Katrina
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2017, 14 (09) : 505 - 505
  • [2] Glucagon is associated with NAFLD inflammatory progression in type 2 diabetes, not with NAFLD fibrotic progression
    Wang, Yuying
    Lin, Zhiqi
    Wan, Heng
    Zhang, Wen
    Xia, Fangzhen
    Chen, Yi
    Chen, Xiaoman
    Wang, Chiyu
    Chen, Chi
    Wang, Ningjian
    Lu, Yingli
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (1S) : E818 - E823
  • [3] Glucagon is associated with NAFLD inflammatory progression in type 2 diabetes, not with NAFLD fibrotic progression
    Wang, Yuying
    Lin, Zhiqi
    Wan, Heng
    Zhang, Wen
    Xia, Fangzhen
    Chen, Yi
    Chen, Xiaoman
    Wang, Chiyu
    Chen, Chi
    Wang, Ningjian
    Lu, Yingli
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 : E818 - E823
  • [4] Adaptive immunity: an emerging player in the progression of NAFLD
    Sutti, Salvatore
    Albano, Emanuele
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2020, 17 (02) : 81 - 92
  • [5] Adaptive immunity: an emerging player in the progression of NAFLD
    Salvatore Sutti
    Emanuele Albano
    Nature Reviews Gastroenterology & Hepatology, 2020, 17 : 81 - 92
  • [6] NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic-Metabolic Interplay
    Cernea, Simona
    LIFE-BASEL, 2024, 14 (02):
  • [7] Acetylation of lactate dehydrogenase B drives NAFLD progression by impairing lactate clearance
    Wang, Tongxin
    Chen, Kai
    Yao, Weilei
    Zheng, Ruilong
    He, Qiongyu
    Xia, Jun
    Li, Juan
    Shao, Yafei
    Zhang, Li
    Huang, Lu
    Qin, Longshan
    Xu, Mingming
    Zhang, Zheng
    Pan, Dingyu
    Li, Zhen
    Huang, Feiruo
    JOURNAL OF HEPATOLOGY, 2021, 74 (05) : 1038 - 1052
  • [8] Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-β
    Hart, Kevin M.
    Fabre, Thomas
    Sciurba, Joshua C.
    Gieseck, Richard L., III
    Borthwick, Lee A.
    Vannella, Kevin M.
    Acciani, Thomas H.
    Prado, Rafael de Queiroz
    Thompson, Robert W.
    White, Sandra
    Soucy, Genevieve
    Bilodeau, Marc
    Ramalingam, Thirumalai R.
    Arron, Joseph R.
    Shoukry, Naglaa H.
    Wynn, Thomas A.
    SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (396)
  • [9] Collagen-amylin crosstalk drives the progression of type 2 diabetes
    Hazari, Md Asrafuddoza
    Kumar, Ashutosh
    Sen, Shamik
    BIOPHYSICAL JOURNAL, 2024, 123 (03) : 490A - 490A
  • [10] C-peptide is associated with NAFLD inflammatory and fibrotic progression in type 2 diabetes
    Wang, Ningjian
    Wang, Yuying
    Zhang, Wen
    Chen, Yi
    Chen, Xiaoman
    Wang, Chiyu
    Li, Qing
    Chen, Chi
    Jiang, Boren
    Lu, Yingli
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2020, 36 (02)
12345